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Abstract
Health education is compulsory for patients with chronic and life-threatening disease, especially for those with diabetes mellitus (DM).
This study aimed to examine the long-term effectiveness of the Diabetes Conversation Map Program (DCMP) among DM patients in
Taiwan.
A quasi-experimental research design using convenience sampling and nonrandom group assignment was applied to recruit 95
type 2 diabetic subjects from a hospital in Taiwan. In addition to routine care, the experiment group (n=49) received 7 sessions of
DCMP that delivered over 2 months, while the control group (n=46) received only routine care during the same period. We
conducted structured questionnaire survey and reviewed medical record at 3 time points (before DCMP, 3 days after DCMP, and 3
months after DCMP completion) to collect the effectiveness data. The effectiveness was determined using the generalized estimating
equation model.
We found that improvements in the body mass index, blood glucose, glycated hemoglobin, self-monitoring of blood glucose, and
diabetic health literacy in the DCMP group compared with controls (all P values <.05), with no significant changes in depressive
symptoms. The positive effects were further maintained for 3 months after DCMP.
The findings may serve as a reference for helping healthcare professionals provide appropriate interventions to improve adaptation
processes and clinical outcomes for DM patients.
Abbreviations: DCMP = Diabetes Conversation Map Program, DM = diabetes mellitus.
Keywords: diabetes conversation map program, diabetes mellitus, effectiveness, generalized estimating equation
1. Introduction
Diabetes mellitus (DM), characterized by hyperglycemia resulting
from defects in insulin activity, is a key challenge worldwide.
Diabetic adults are estimated to equal 285million and 439million
in the years 2010 and 2030, respectively, representing an increase
of nearly 55%.[1] Given the complex symptoms and long duration
ofDM, the high costs of diseasemanagement cannot be ignored. A
report by the American Diabetes Association indicated that the
direct medical costs of DM in the United States in 2012 were $69
billion, with the total societal costs (the sum of direct and indirect
costs) estimated to exceed $245 billion.[2]
DM not only causes enormous economic burdens but also
triggers major challenges for human health worldwide. The
guidelines by American Diabetes Association suggest that target
blood glucose levels for diabetes control should be 70 to 130mg/
dL before meals and <180mg/dL after meals, and glycated
hemoglobin A1c (HbA1c) concentration should be less than
7%.[3] Once DM patients exhibit poor glucose control, adverse
complications can possibly occur. A study reported that, in
comparison with patients with HbA1c <6%, those with HbA1c
levels ranging from 7.0 to 7.9% had a 1.14-fold greater risk of
cardiovascular disease, and a 25% increased risk of microvascu-
lar complications during a 4-year tracking period.[4] Andersson
et al[5] also found that each unit increase in HbA1c of DM
patients was related to an increase in the mortality rate by 22%.
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As a consequence, tight glycemic control is imperative for DM
patients to improve prognosis.
Health education is the cornerstone of glycemic control for
diabetic patients. The majority of conventional health education
programs were developed using existing knowledge administered
in a 1-way format.[6–8] These programs, however, seem to be
unable to fully grasp the plight of DM patients in achieving
glycemic control.[9,10] To fill this gap, Healthy Interactions, the
International Diabetes Federation, and diabetes scholars have
created the “Diabetes Conversation Map Program” (DCMP), a
health education program that has been adopted by more than
100 countries worldwide.[11] DCMP is built on patient-centered
and conversation-based approaches, encouraging DMpatients to
participate in the drafting of applicable glycemic control
strategies in an empowered learning environment, and further
strengthening patients’ self-care ability through interactive
discussion.[12,13]
Despite many reports on the effects of DCMP, the effectiveness
of DCMP as an education intervention remains contradictory. For
example, Ciardullo et al[14] used the single-group pretest–posttest
design to assess the effects of DCMPon 63DMpatients and found
that the level of fasting plasmaglucose (FPG) decreased from152.9
to 138.2mg/dL, HbA1c levels decreased from 8.2% to 7.8%, and
body mass index (BMI) decreased from 27.6 to 25.5kg/m2 (all
P< .05). Another study also proposed that DCMP could boost
patients’ self-care efficacy positively relative to traditional health
education.[15] Nevertheless, 1 report showed that bothDCMP and
traditional health education were able to reduce HbA1c levels, by
0.27%and 0.24%, respectively, butwith no significant differences
in performing twice-daily self-monitoring of blood glucose
(SMBG) (35.9% vs 33.8%).[16] Of note, the direct application
to residents in Chinese may not be appropriate due to significant
differences in the environment, life style, economic and physical
conditions, and the existing geography.
By the end of 2012, at least 90 hospitals in Taiwan had offered
DCMP courses.[17] Although several studies have been conducted
in Taiwan to measure the effectiveness of DM health education,
these studies were limited to traditional health education
strategies and only focused on changes in patients’ self-care
knowledge or behavior.[6,18,19] In addition, they mostly ignored
the assumption of independence among the patients’ responses
and did not consider maturation effects over time, possibly
blunting effectiveness of the interventions.[20,21] To narrow this
gap in the literature, this pretest–posttest study aimed to evaluate
the effects of DCMP for DM patients in Taiwan by using a
generalized estimating equations (GEE) model, with the intent
that the findings could serve as a reference for providing
empirically robust grounds for healthcare providers to formulate
more appropriate interventions for DM patients.
2. Methods
2.1. Study design and participants
A quasi-experimental research design using convenience sam-
pling and nonrandom group assignment was used to recruit
participants from the endocrinology department of a hospital in
Taiwan from January toMay of 2014. The inclusion criteria were
being at least 20 years old at the time of recruitment, having no
cognitive impairment and severe complications, being able to
express opinions in either Mandarin or Taiwanese, and having
been diagnosed with DM by an endocrinologist. To ensure
participants’ anonymity, all questionnaires were marked with an
encryption code to facilitate data analysis, but with no personal
identifiers.
2.2. Sample size calculation
The sample size needed for this study of repeated measures was
estimated by using the methodology of Cohen,[22] where a was
set to 0.05, power was set to 0.8, and the effect size was set to 0.2
that focused on the changes in HbA1c level between 2
groups.[14,16] It was determined, based on these psychometrics,
that a sample of at least 68 patients (each group including 34
cases) was required for sound data analysis (based on the G-
POWER 3.1 analytical software, Franz Faul, Universitat Kiel,
Kiel, Germany).
2.3. Intervention
Because continued participation was essential for this study,
participants were divided into experiment or control groups in
accordance with their personal preference. Study flowchart of
this work is shown as Fig. 1. Participants in the control group
received usual health education lasting for about 20 minutes after
per medical visit which consisted of consultation from ward
nurses on disease symptoms, related treatment options, and
clarification of doctors’ orders. They were also encouraged to ask
questions of the research team, their ward nurses and physicians
at any time within the duration of the study.
Participants of the experimental group received 7 DCMP-
based group education sessions (10–12 participants, 1.5hours
each) for 7 consecutive weeks in addition to routine health
education at a private room in the outpatient unit. One registered
nurse who received DCMP facilitator training, from the
Taiwanese Association of Diabetic Educators, served as the
class facilitator. DCMP sessions were conducted using 7 colored
“maps” covering different topics, including “walk with diabe-
tes,” “what is diabetes?”, “a healthy diet and exercise,” “walk
with insulin,” “diabetes complications and related risk factors,”
“foot care for diabetes patients,” and “a type 1 diabetes patient in
the home.” Each map, a laminated 3-by-5-foot table-top visual
with colorful drawings as metaphors of situations familiar to DM
patients, was placed on a table with participants gathered around
it. This procedure served to create mutual imagery to be shared
with participants. In addition to using these colored maps, the
facilitator further offered participants self-designed conversation
cards and asked them to share individual glycemic control
experiences based on the questions shown on the cards. This
interactive learning environment allowed patients to discuss the
effects of the illness, its treatment, and changes in the self-image,
roles, and relationships with family members, friends or
coworkers; and furthermore to distinguish related diabetic care
facts from myths.[23] All the strategies were rationally systemati-
cally planned and, when needed, modified in accordance with the
individualized therapeutic regimen offered to the patient, and in
consultation with his or her family, the physician, or any other
members of the medical team. Additionally, the nonscheduled
telephone follow-up calls during the study period were also
implemented to assess the patients’ condition and to discuss any
problems that may have arisen, depending on participants’ needs.
2.4. Outcome measures
The primary outcomes comprised the weekly SMBG times and
several biochemical parameters containing BMI, HbA1c, and
Hung et al. Medicine (2017) 96:36 Medicine
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FPG through patients’ medical records review. In addition, the
depressive symptoms as well as the level of DM health literacy
were also measured, which were determined by the Taiwanese
Depression Questionnaire (TDQ) and a self-administered
questionnaire regarding DM health literacy.
TDQ, created by Lee et al,[24] is a structured interview that has
been validated against the Diagnostic and Statistical Manual of
Mental Disorders (Third Edition). It assesses depressive symptom
in the preceding week with 18 self-reported items that are rated
on a Likert scale ranging from 0 to 3. Thus, the TDQ total score
ranges from 0 to 54, where higher scores indicate a higher level of
depressive symptom. We adopted the TDQ because it is easy to
administer, well adapted to the Asian culture, and uses the
Taiwanese language. TDQ has been shown to have good internal
consistency by various previous studies in assessing the depressive
symptom, with Cronbach a values between 0.89 and 0.92.[25–27]
The Cronbach a in our study was 0.93.
The DM health literacy questionnaire was developed by the
primary investigators. It contained 20 items and was scored using
a 5-point Likert scale, with higher total scores indicating
more positive diabetic health literacy. Regarding psychometric
properties, the questionnaire was assessed for content validity by
5 experts from several disciplines, including 3 endocrinologists, a
nurse supervisor, and a nursing professor in the endocrinology
field. The questionnaire was reviewed for clarity and appropri-
ateness and revised based on the experts’ feedback and
suggestions. The questionnaire was acceptable if the index of
content validity was >0.80. Scale reliability was indicated by
Cronbach a of 0.90.
2.5. Covariates
Additional items addressing demographic and disease character-
istics were developed based on clinical experience and literature
review,[28] andwere collected at study entry via patient interviews
and medical records. Demographic data included sex, age,
marital status, education level, religion, household status,
monthly income, and certain lifestyle factors, such as smoking,
exercise habits, and presence of sleep disturbances. Smoking
status was recorded as “non-smoker” or “current or ex-smoker.”
Those who exercised regularly (i.e., weekly) were classified as
having “exercise habits.” Sleep disturbances were defined as
Subjects with DM who had not 
received the DCMP (n=46)
DM patients who received
the DCMP (n=49)
• Assessment and problem 
listing
1st measure (T0) (n=49)
• Introduce DCMP intervention
• Receive the booklet
• Seven DCMP-based group 
education sessions for seven 
consecutive weeks
2nd measure (T1) (n=46) 2nd measure (T1) (n=49)








• Assessment and problem 
listing
1st measure (T0) (n=46)
• Received usual health 
education lasting for about 20
minutes per medical visit from 
ward nurses
Eligible patients were recruited
•
Figure 1. Study flow diagram.
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waking up at night more than twice without external factors
during the week before the interview. Disease characteristics
included the presence of chronic disease (i.e., stroke, hyperten-
sion, heart disease, renal disease, or cancer), medication regimen,
and duration of DM.
2.6. Data collection procedure
The study protocol was approved by the Research Ethics
Committee of Dalin Tzuchi Hospital (No. B10002009) and
registered in the ClinicalTrials.gov (NCT02733315). At study’s
initiation, researchers explained the purpose of study and its
procedure to all participants. Signed informed consent was
obtained after the patients understood and agreed to participate
in this study. Thereafter, we applied an observer-blind approach
for data collection. A trained interviewer, who was not familiar
with participants and with the study design, was assigned to
collect the information pertaining to the outcome variables and
covariates. All data were obtained at 3 time points: beforeDCMP
(T0), 3 days after DCMP (T1), and 3 months after DCMP (T2).
To reduce the dropout rate, researchers asked participants to
return the hospital for the completion of assessments via phone
reminders. All the participants were followed from the date of
enrollment until the end of the follow-up, but theywere still given
the option to withdraw from the study at any time without any
penalty.
2.7. Statistical analysis
Descriptive and inferential statistical analyses were conducted in
accordance with the study aims and the nature of the variables.
Descriptive parameters, including mean, standard deviation, and
percentage, were used to describe the distributions of demo-
graphic and disease data. Differences between the 2 groups were
compared initially using t test and x2 test as appropriate. For
inferential analysis, we used GEE procedure with identity link
function with normal distribution to assess the long-term effects
of DCMP, while taking into account within-subject correlations
between measurements over time and the influence of potential
confounding covariates. All the analyses were conducted using
SAS version 9.3 (SAS Institute Inc, Cary, NC), and P< .05 was
considered significant.
3. Results
3.1. Demographic and disease characteristics
of participants
A total of 95 patients with type 2 DMwere enrolled in the study,
with 49 in the experiment group and 46 in the control group. All
of them completed the follow-up of this study. Overall, patients
aged from 39 to 80 years with a mean of 61.3 (SD=8.0) years.
Most patients were male (51.6%), married (80.0%), and
cohabitating with other people (84.2%) and had a low level of
education (54.7%, defined as below 9th grade). Additionally,
most participants reported having religious beliefs (72.6%), a
monthly income 30,000 New Taiwan Dollar (69.5%), exercise
habits (64.2%), and sleep disturbances (55.8%). Over 80% of
the participants were nonsmokers (82.1%). In terms of disease
characteristics, the majority of the participants had diabetes for
more than 5 years (76.8%), and used oral hypoglycemic agents
and insulin injections (89.5%). Most patients presented with
comorbidities (70.5%).Mean scores of depressive symptoms and
DM health literacy were 8.6 and 65.2, respectively. The average
number of SMBG in 1 week was 1.7, and the mean levels of BMI,
HbA1c, and FPG were 27.2kg/m2, 8.0%, and 164.9mg/dL,
respectively.
3.2. Baseline comparison of demographic and disease
characteristics between 2 groups
Significant differences were found between the 2 groups in age
(P= .01), medication usage (P= .04), disease duration (P= .01),
DM health literacy (P= .01), and FPG (P= .02) (Table 1).
3.3. Effects of DCMP on depressive symptoms, DM health
literacy, and SMBG
Table 2 displays the GEE analysis regarding the long-term
effectiveness of DCMP for DM patients. First, no significant
differences were found in baseline depression scores between the
experiment and control groups. The depression scores at T1 and
T2 were also not statistically different from those at T0, revealing
that no maturation effect occurred in this model. The DCMP
intervention did not reduce the level of depressive symptoms in
either group after adjusting for baseline differences such as age,
medication usage, and disease duration. Regarding DM health
literacy, a maturation effect was found at T2 that was
significantly higher than that initially measured in the control
group (P= .02). In addition, the initial DM health literacy scores
were significantly lower in the experiment group than in the
control group (P< .01). After controlling for age, medication
usage, disease duration, and maturation effect, we found DCMP
was more beneficial to increase DM health literacy in the
experiment group than that in the control group at T1 and T2,
with the B values of 4.55 and 3.22 (all P values< .05). For SMBG,
multivariate analyses using the GEE model revealed that the
maturation effect did not occur and that the 2 groups appeared to
begin with equivalent levels of SMBG at baseline. DCMP
significantly enhanced the frequency of weekly SMBG in DM
patients at T1 and T2. In particular, the SMBG times of the
experimental group, at T2, were significantly higher than these of
the control group by nearly twice, weekly (B=1.97; P= .001).
3.4. Effects of DCMP on biochemical parameters
No significant differences were found in the BMI between the 2
groups at T0. Additionally, the control group showed no
maturation effect at either T1 or T2. Multivariate analyses
revealed that the reduction slope of BMI in the experiment group
was greater than that in the control group at T1 and T2 after
adjusting for age, medication usage, and disease duration, with
the B values of 0.40 and 1.73, respectively. (Both P
values< .05). Also, no significant differences were found in
HbA1c levels between the 2 groups at T0, and no maturation
effect was found in the control group. After controlling for age,
medication usage, and disease duration by the GEE model, we
found that the reduction slope of HbA1c was significantly greater
in the experiment group than that in the control group at T2
(B=0.70; P= .01). On the other hand, the GEEmodel indicated
that the difference of FPG between 2 groups at T0, and a
maturation effect, might have occurred when considering if
DCMPwas beneficial in glycemic control. After adjusting for age,
medication usage, disease duration, and maturation effect,
DCMP was still found to be beneficial in reducing the FPG level
Hung et al. Medicine (2017) 96:36 Medicine
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of DM patients at T2 as compared with the control group,
yielding the B value of 46.93 (P< .01).
4. Discussion
Although some previous studies have been conducted to
determine the effectiveness of traditional health education
programs for DM, the results of these studies may have been
biased due to inadequate samples, short follow-up periods, or
inappropriate statistical methods. To the best of our knowl-
edge, this is the first study to assess the effectiveness of DCMP
from a long-term tracking perspective. In contrast to prior
research, the GEE model used in this study provided further
control of participants’ attributes at baseline and of temporal
maturation effect, allowing us to better determine the
effectiveness of DCMP.
Despite the experiment group showing a larger reduction slope
in depression scores than the control group, following the
implementation of DCMP, the improvement did not reach
statistical significance. We speculate that the initial depressive
symptom levels among the participants were not severe, possibly
reducing the influence of DCMP. Our findings, however, differed
from earlier reports that supported the alleviation of depressed
mood in DM patients following DCMP.[16,23] This inconsistency
may be associated with the difference in the screening tools for
depression and the statistical analysis methods used. Some
previous studies used PHQ-9[16] and Problem Areas in Diabetes
Questionnaire [23] to examine the level of depressive symptoms,
Table 1
Demographic and clinical characteristics of study participants by group.
Variables
All participants (n=95) DCMP group (n=49) Control group (n=46)
Pn % n % n %
Sex .13
Male 49 51.6 29 59.2 20 43.5
Female 46 48.4 20 40.8 26 56.5
Marital status .15
Married 76 80.0 42 85.7 34 73.9
Single 19 20.0 7 14.3 12 26.1
Educational level .25
<9th grade 52 54.7 24 49.0 28 60.9
≥9th grade 43 45.3 25 51.0 18 39.1
Household status .47
Alone 15 15.8 9 18.4 6 13.0
Cohabitating 80 84.2 40 81.6 40 87.0
Monthly income .67
30,000 NTD 66 69.5 35 71.4 31 67.4
>30,000 NTD 29 30.5 14 28.6 15 32.6
Religious belief .51
No 26 27.4 12 24.5 14 30.4
Yes 69 72.6 37 75.5 32 69.6
Regular exercise .51
No 34 35.8 16 32.7 18 39.1
Yes 61 64.2 33 67.3 28 60.9
Cigarette smoking .90
No 78 82.1 40 81.6 38 82.6
Yes 17 17.9 9 18.4 8 17.4
Sleep disturbance .17
No 42 44.2 25 51.0 17 37.0
Yes 53 55.8 24 49.0 29 63.0
Medication usage .04
Insulin injection only 10 10.5 2 4.1 8 17.4
Insulin injection + OHA
∗
85 89.5 47 95.9 38 82.6
Disease duration
5 y 22 23.2 6 12.2 16 34.8 .01
>5 y 73 76.8 43 87.8 30 65.2
Comorbidity .80
No 28 29.5 15 30.6 13 28.3
Yes 67 70.5 34 69.4 33 71.7
Mean SD Mean SD Mean SD
Age, y 61.3 8.0 63.9 9.3 58.5 9.1 .01
Depression score 8.6 8.0 8.4 7.4 8.8 8.5 .81
DM health literacy score 65.2 5.5 63.3 5.4 67.1 4.6 .01
Body mass index, kg/m2 27.2 4.7 26.7 4.9 27.7 4.5 .34
HbA1c, % 8.0 1.5 8.1 1.5 7.9 1.5 .56
FPG, mg/dL 164.9 52.3 176.9 60.8 152.2 38.1 .02
SMBG, time/wk 1.7 2.4 1.4 2.3 2.0 3.2 .59
DM = diabetes mellitus, FPG = fasting plasma glucose, SMBG= self-monitoring of blood glucose.
∗
Oral hypoglycemic agents.
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which are distinctly different from the scale (TDQ) used in the
present study. Furthermore, previous studies did not take into
consideration the interfering influence of maturation effect on the
effectiveness of the intervention studied. In the present study,
apart from adjusting for baseline differences between the 2
groups using the GEE model, this analytic method further took
into consideration the impact of maturation effect over time, thus
allowing for more robust conclusions.[20,21]
DCMP enhanced the level of DM health literacy in the
experiment group compared with that in the control group, who
only received routine care and did not participate in an education
program. This effect was maintained for 3 months following the
completion of DCMP sessions, echoing with the findings in some
previous studies of DCMP in Western populations.[16,23,29]
Furthermore, our study further supports that DM health literacy
positively influenced the health-promoting behaviors of DM
patients.[30] For instance, following DCMP, the frequency of
weekly SMBG in the experiment group was higher than that in
the control group. It can be inferred that most traditional health
education programs merely rely on established structured
processes and proceed with educational leaflets. This type of
1-direction administration may lead to the quick dissipating of
the learning effect. In contrast, the facilitators of DCMP
introduce the concepts, pathologies, and treatment regimens of
DM through a coordinated use of colored maps and group
discussion. This process may insidiously strengthen knowledge
and behaviors in diabetic care among DM patients.[13,31]
Nevertheless, a previous study observed a different effect on
SMBG from that in the present study,[16] and this inconsistency in
findings may be because that the previous study classified SMBG
into 2 parts based on whether SMBG exceeded twice a week,
while the present study treated SMBG as a continuous variable.
In the present study, the experiment group had a significantly
greater reduction in BMI than the control group, and this effect
was maintained for 3 months following completion of DCMP.
This could be attributable to the inclusion, in the DCMP sessions,
of the topic “healthy diet and exercise.” Patients with DM were
encouraged in this class to lose weight through regular exercise
and diet, which is beneficial in reducing the subsequent risk of
cardiovascular diseases. However, the finding contradicts those
in some reports fromWestern countries,[16,23,29] which may stem
from the difference in the level of awareness of health burdens
caused by obesity. In fact, at similar BMI levels, a higher body fat
percentage was found in Asians in comparison to Caucasians,
and consequently, a greater risk of death by 10% for Asians.[32]
Furthermore, this inconsistency may also be associated with the
statistical analyses employed in these studies. Previous studies
relied mostly on univariate analyses to compare effects of
pre–post education intervention, rather than adopting a more
comprehensive multivariate model that controls for potentially
intervening covariates (maturation effect, in particular), thus
failing to accurately verify the effectiveness of DCMP.
The results of the present study demonstrated that DCMPhas a
positive effect on glycemic control, echoing the results of some
earlier reports.[16,23,29] DCMP differs from traditional methods
by using a highly interactive approach and colored images to
more actively engage patients with the health information they
are learning and to help them make appropriate plans for
glycemic control. It is noteworthy that most participants in this
study were older adults, and nearly 60% had low educational
levels. Previous studies have demonstrated that older patients and
those from low education levels often have poorer medical
adherence.[33,34] Therefore, DCMP may be a useful approach
when health education is provided to seniors or to patients with
low education levels.
In assessing the 3-month effectiveness of DCMP, we used the
GEE model to adjust for baseline differences and temporal
maturation effect, allowing a more robust determination. Several
limitations, however, should be noted when interpreting the
results. First, all the participants were drawn from a single
hospital in southern Taiwan, so inferences drawn from the results
might not be generalizable to populations in other geographic
regions. Previous research, however, has also often been limited
by such factors as participants’ ethnicity, geographic location,
nationality, and the nature of the medical data available,
suggesting that this limitation is not unique to our study. Second,
the application of a quasi-experimental comparative research
design, rather than conducting a randomized clinical trial, may
have weakened the internal validity of the research because of the
presence of potentially confounding variables. Nevertheless, we
have employed the GEE model to control for baseline differences
between the 2 groups, and further considered the potential
maturation effects, which would likely reduce the probability of
inflated type I error to some extent.[20] Third, the data on the
Table 2
GEE analysis of the effectiveness of DCMP for diabetic patients (n=95).
Variables
Depression score DM health literacy score SMBG (time/weekly) HbA1c FPG (mg/dL) BMI (kg/m2)
B SE B SE B SE B SE B SE B SE
Age, y 0.19∗ 0.09 0.03 0.38 0.03 0.02 0.02 0.01 0.04 0.45 0.13∗ 0.05
Medication usage 1.33 2.29 1.63 0.84 0.87 1.40 0.21 0.50 8.83 16.22 1.17 1.97
Duration of diabetes mellitus 0.32 1.64 0.77 0.80 0.93 0.59 0.82† 0.23 17.72
∗
7.95 0.49 1.23
Group (experiment/control) 0.40 1.80 3.58† 1.09 0.53 0.67 0.10 0.33 22.16∗ 10.76 0.17 0.93
T1‡ (vs T0x) 1.91 1.11 0.97 0.76 0.24 0.29 0.23 0.29 11.28∗ 6.49 0.11 0.10
T2jj (vs T0) 0.94 0.87 1.83∗ 1.01 0.15 0.29 0.22 0.21 1.50 9.64 0.12 0.19
Interaction of T1 and group 0.21 1.35 4.55† 1.29 0.82∗ 0.59 0.22 0.31 12.44 8.72 0.40∗ 0.15
Interaction of T2 and group 1.07 1.18 3.22∗ 1.32 1.97† 0.57 0.70∗ 0.25 46.93† 11.98 1.73† 0.41
B: It is a regression coefficient that gained from GEE analysis. Positive values indicate that the positive effects, and vice versa.
BMI = body mass index, DCMP = diabetes conversation map program, DM = diabetes mellitus, FPG = fasting plasma glucose, GEE, generalized estimating equations, SE= standard error, SMBG= self-




‡ Three days after intervention.
x Before intervention.
jj Three months after intervention.
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adherence were unavailable for the study and, accordingly,
caution should be exercised when interpreting these findings.
However, former studies indicated that HbA1c, implying
individual blood glucose (blood sugar) control for the past 2
to 3 months, could be assumed as a surrogate variable for the
compliance level because the poor glycemic control is more
common among patients with low adherence to medica-
tions.[35,36] To address this issue, we performed a sensitivity
analysis that further controlled for the HbA1c while assessing the
DCMP intervention effectiveness. Similar to the initial results of
Table 2, DCMP still exerted positive effects on diabetic
prognostics with the exception of depressive level of DM
patients, suggesting that the level of compliance did not
appreciably influence the relationships reported earlier. Fourth,
the possible existence of the Hawthorne effect should also be
considered. Nonetheless, all the participants were divided into the
2 groups and then the bias (if any) was likely to lead to
underestimation of effects. The long-term measurement
employed helped in reducing the influence of the Hawthorne
effect in light of the law of diminishing marginal utility.[36]
5. Conclusion
In conclusion, an appropriate health education intervention can
assist DM patients in coping with their condition and enhancing
their self-care ability. This study demonstrated DCMP could
effectively increase the frequency of weekly SMBG and the DM
health literacy levels among Taiwanese DM patients. Addition-
ally, DCMP had positive effects on biochemical parameters such
as BMI, FPG, and HbA1c. These effects further persisted for 3
months following the completion of DCMP. Data from the long-
term measurement allow healthcare providers to more confi-
dently consider the practicability of DCMP for DM patients. The
concepts of DCMPmight be applicable to participants with other
chronic diseases, which may be beneficial in progressively
adapting to their disease and improving their clinical outcomes.
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